Related Experiment Video

Updated: May 30, 2026

Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells
12:44

Use of LysoTracker to Detect Programmed Cell Death in Embryos and Differentiating Embryonic Stem Cells

Published on: October 11, 2012

Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases

Andreas Strasser1, Suzanne Cory, Jerry M Adams

  • 1The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. strasser@wehi.edu.au

The EMBO Journal
|August 25, 2011
PubMed

Insights

Apoptosis, or programmed cell death, is vital for development and immunity. Dysregulation of apoptosis contributes to diseases like cancer, and understanding its mechanisms offers therapeutic potential.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Apoptosis is a fundamental process of programmed cell death in metazoans, crucial for development, tissue homeostasis, and immunity.
  • Aberrant apoptosis regulation is implicated in various pathologies, including cancer, autoimmune diseases, infections, and degenerative disorders.
  • Two primary apoptotic pathways exist in vertebrates: death receptor-mediated and mitochondrial-mediated, both converging on caspase activation.

Purpose of the Study:

  • To review the groundbreaking experimental findings that have elucidated the mechanisms of cell death regulation.
  • To highlight the translation of this knowledge into potential novel therapeutic strategies.
  • To discuss the application of apoptosis research in treating malignant, autoimmune, and infectious diseases.

Main Methods:

  • This review synthesizes findings from numerous laboratories worldwide.
  • It focuses on experimental data clarifying cell death regulation pathways.
  • The review examines the complex interactions within the Bcl-2 protein family and death receptor signaling.

Main Results:

  • Significant progress has been made in understanding the molecular intricacies of apoptosis.
  • The roles of death receptors, the Bcl-2 family, and caspases in cell death have been clarified.
  • Translational research is actively exploring therapeutic applications based on these findings.

Conclusions:

  • Understanding apoptosis mechanisms is critical for addressing numerous human diseases.
  • Targeting apoptotic pathways holds promise for developing novel treatments for cancer and other disorders.
  • Continued research is essential for translating fundamental discoveries into effective clinical interventions.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...